About Murli Krishna Exports
Murli Krishna Exports is a company based in Mumbai (India) founded in 1999. It operates as a B2B. Murli Krishna Exports operates in a competitive market with competitors including Laurus Labs, Symbiotec, Provepharm Life Solutions, Beijing Biostar Technologies and SeQuent, among others.
- Headquarter Mumbai, India
- SectorsIndustrial Goods & Manufacturing
- Email••••••••
- Website mkepl.com
- Social Facebook
- Legal Name Murli Krishna Exports Private Limited
- Date of Incorporation 13 Oct, 1999
- Jurisdiction Mumbai, Maharashtra, India
- Annual Revenue₹50.20 Cr
FY 2025 · +58% YoY
- Net Profit₹3.44 Cr
FY 2025 · 7% margin
- EBITDA₹4.99 Cr
FY 2025 · 10% margin
Associated legal entities of Murli Krishna Exports
Murli Krishna Exports operates through Murli Krishna Exports Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Murli Krishna Exports Private Limited CIN U46101MH1999PTC122200 | Active | 13 Oct 1999 | Mumbai, Maharashtra | ₹50.2 Cr | – | 3 | View details |
Board of directors of Murli Krishna Exports Private Limited (Murli Krishna Exports)
Murli Krishna Exports Private Limited is the primary company behind Murli Krishna Exports. The board of Murli Krishna Exports Private Limited currently have 3 directors; the longest-serving is Seetamahalaxmi Challa, appointed in 1999. 4 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Seetamahalaxmi Challa DIN 00008471 | Whole-time director | 13 Oct 1999 | 26 yrs 11 mo | Murli Krishna Exports Private Limited |
| Vipul Kishorebhai Gondhiya DIN 00009182 | Managing Director | 13 Oct 1999 | 26 yrs 11 mo | Murli Krishna Exports Private Limited |
| Urmin Vipul Gondhiya DIN 09795020 | Director | 22 Nov 2022 | 3 yrs 10 mo | Murli Krishna Exports Private Limited |
Financials of Murli Krishna Exports
Figures of Murli Krishna Exports Private Limited, the primary company behind Murli Krishna Exports, for FY 2025. Revenue was ₹50.20 Cr (+58% year on year). Net profit was ₹3.44 Cr (7% margin). EBITDA was ₹4.99 Cr (10% margin). Revenue has grown at a compounded annual rate of +38% over three years and +6% over five years.
- ₹50.20 CrRevenue · FY 2025 · +58% YoY
- ₹3.44 CrNet profit · 7% margin
- ₹4.99 CrEBITDA · 10% margin
- ₹20.1 LakhPaid-up capital
- +38%Revenue CAGR, 3 years
- +6%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Murli Krishna Exports Private Limited are on its company page.
Detailed financial statements for Murli Krishna Exports
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Competitors of Murli Krishna Exports
Murli Krishna Exports operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Laurus Labs, Symbiotec, Provepharm Life Solutions, Beijing Biostar Technologies and SeQuent, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| lauruslabs.com | 2005 | Hyderabad, India | $229.73M | 6,035 | Pharmaceutical and biotechnology company | |
| symbiotec.in | 2002 | Indore, India | $61.01M | 1,822 | Non-sterile steroid hormone-based APIs and intermediates are manufactured. | |
| provepharm.com | 1998 | Marseille, France | $145.93M | – | APIs and drug products are developed and valorized in pharmaceuticals. | |
| biostar-pharm.com | 2002 | Beijing, China | $135.23M | – | APIs, intermediates, and biochemical reagents are developed and manufactured. | |
| sequent.in | 2002 | Bengaluru, India | – | – | APIs are developed and manufactured for therapeutic areas. | |
| sterlingpharmasolutions.com | 2016 | Dudley, United Kingdom | – | 560 | Contract development, manufacturing, and analytical services for APIs are offered. | |
| snapdragonchemistry.com | 2014 | Cambridge, United States | – | 43 | Drug discovery and development service provider | |
| jubilantpharma.com | 1978 | Noida, India | – | – | Pharmaceuticals, APIs, and radiopharmaceuticals are manufactured by the company. | |
| hikal.com | 1988 | Mumbai, India | – | 355 | APIs and intermediates are produced via custom synthesis and research. |
Detailed competitors of Murli Krishna Exports
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Similar companies to Murli Krishna Exports
10 companies that operate in the same segment as Murli Krishna Exports (Metals & Minerals), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
3M is recognized as a global leader in industrial innovation. | 1902 | United States | – | USD 24.95 B | 74 | |
Diversified products are provided across health, lighting, and consumer sectors. | 1891 | Amsterdam, Netherlands | – | USD 20.95 B | 67,820 | |
Diversified conglomerate operating across multiple industries | 1919 | Tokyo, Tokyo, Japan | – | USD 45.77 B | 73 | |
Traditional conglomerate services are provided across multiple sectors by Mitsui. | 1947 | Chiyoda, Tokyo, Japan | – | USD 87.78 B | 146 | |
Metals and minerals are produced and supplied worldwide. | 1974 | Baar, Zug, Switzerland | USD 2.2 B | USD 252.73 B | 150,000 | |
Multiple real estate strategies are pursued by Al-Futtaim. | 1930 | Dubai, Dubai, United Arab Emirates | USD 500 M | – | – | |
Mineral-based specialty solutions are supplied for industrial applications. | 1880 | Paris, France | USD 1.56 B | USD 3.97 B | 12,900 | |
Manufacturer of pipes, plates & coils, and home textile products | 1985 | Mumbai, Maharashtra, India | USD 544.43 M | – | 6,934 | |
Private equity firm focused on energy, chemical, semiconductor, logistics, and multiple sectors | 1953 | Seoul, South Korea | – | USD 14.38 M | 1 | |
Chemical and casting products are manufactured, with shipping operations managed. | 1962 | Chennai, Tamil Nadu, India | USD 573.4 M | USD 1.43 B | 180 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Murli Krishna Exports
Murli Krishna Exports was founded in 1999.
Murli Krishna Exports is headquartered in Mumbai, India. It is registered at Mumbai, Maharashtra, India.
The primary company behind Murli Krishna Exports, Murli Krishna Exports Private Limited, reported revenue of ₹50.20 Cr for FY 2025, up 58% year on year.
Murli Krishna Exports operates with a B2B model, focusing on pharmaceuticals and chemicals, ingredient manufacturing, exports, and api and ingredients. Manufactures and exports pharmaceutical, veterinary, cosmetics, and animal feed ingredients to international markets. It emphasizes efficiency, client-focused solutions, and growth, fostering partnerships and innovation in its operations.
Murli Krishna Exports's top competitors include Laurus Labs, Symbiotec and Beijing Biostar Technologies.
Murli Krishna Exports operates through Murli Krishna Exports Private Limited.
The legal entities of Murli Krishna Exports currently have 3 directors, including Urmin Vipul Gondhiya, Seetamahalaxmi Challa, Vipul Kishorebhai Gondhiya.